Marex Group’s Cohen & Steers CNS Stock Holding History

Marex Group’s Portfolio CNS Stock Details CNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,701	Closed	-$421K	–	1060
2025 Q4	$421K	Buy	+6,701	New	+$436K	﹤0.01%	611

Other funds holding CNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Marex Group's CNS Position: Q1 2026 in Review

Marex Group sold out of Cohen & Steers (CNS) in Q1 2026, closing a stake of 6,701 shares — an estimated $421K sold.

Marex Group first reported a position in CNS in Q4 2025 and held it in 1 quarter. The position peaked at $421K in Q4 2025. 295 funds tracked by Wall St. Rank hold CNS as of Q1 2026.

Marex Group reported no remaining Cohen & Steers position as of Q1 2026 after selling out during the quarter.
Marex Group sold 6,701 Cohen & Steers shares in Q1 2026, an estimated $421K.
Marex Group first reported a position in Cohen & Steers in Q4 2025 and held it in 1 quarter.
Marex Group's Cohen & Steers position peaked at $421K in Q4 2025.
295 funds tracked by Wall St. Rank held Cohen & Steers as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.